In addition to chronic BCR-activated leukemia and lymphoma, HSP90 also cooperates with BCR signaling in Burkitt lymphoma (BL) as it interacts with SYK in a BCR Y197-dependent manner [68]. Here, HSP90AA1 is linked to leukemia.